Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease.

Kao MP, Ang DS, Gandy SJ, Nadir MA, Houston JG, Lang CC, Struthers AD.

J Am Soc Nephrol. 2011 Jul;22(7):1382-9. doi: 10.1681/ASN.2010111185. Epub 2011 Jun 30.

2.

Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.

Miao Y, Ottenbros SA, Laverman GD, Brenner BM, Cooper ME, Parving HH, Grobbee DE, Shahinfar S, de Zeeuw D, Lambers Heerspink HJ.

Hypertension. 2011 Jul;58(1):2-7. doi: 10.1161/HYPERTENSIONAHA.111.171488. Epub 2011 May 31.

3.

Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease.

Stenvinkel P.

J Intern Med. 2010 Nov;268(5):456-67. doi: 10.1111/j.1365-2796.2010.02269.x. Review.

4.

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.

Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincón A, Arroyo D, Luño J.

Clin J Am Soc Nephrol. 2010 Aug;5(8):1388-93. doi: 10.2215/CJN.01580210. Epub 2010 Jun 10.

5.

Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients.

Momeni A, Shahidi S, Seirafian S, Taheri S, Kheiri S.

Iran J Kidney Dis. 2010 Apr;4(2):128-32.

6.

High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.

Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS.

Diabetes Care. 2010 Jun;33(6):1337-43. doi: 10.2337/dc10-0227. Epub 2010 Mar 23.

7.

Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study.

Jalal DI, Rivard CJ, Johnson RJ, Maahs DM, McFann K, Rewers M, Snell-Bergeon JK.

Nephrol Dial Transplant. 2010 Jun;25(6):1865-9. doi: 10.1093/ndt/gfp740. Epub 2010 Jan 11.

8.

Association between serum uric acid and development of type 2 diabetes.

Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, Saito A, Sone H.

Diabetes Care. 2009 Sep;32(9):1737-42. doi: 10.2337/dc09-0288. Epub 2009 Jun 23.

9.

Uric acid as a marker for renal dysfunction in hypertensive women on diuretic and nondiuretic therapy.

Borges RL, Hirota AH, Quinto BM, Ribeiro AB, Zanella MT, Batista MC.

J Clin Hypertens (Greenwich). 2009 May;11(5):253-9.

PMID:
19534022
10.

Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients.

Park JT, Kim DK, Chang TI, Kim HW, Chang JH, Park SY, Kim E, Kang SW, Han DS, Yoo TH.

Nephrol Dial Transplant. 2009 Nov;24(11):3520-5. doi: 10.1093/ndt/gfp272. Epub 2009 Jun 2.

PMID:
19491381
11.

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice.

Kosugi T, Nakayama T, Heinig M, Zhang L, Yuzawa Y, Sanchez-Lozada LG, Roncal C, Johnson RJ, Nakagawa T.

Am J Physiol Renal Physiol. 2009 Aug;297(2):F481-8. doi: 10.1152/ajprenal.00092.2009. Epub 2009 May 20.

12.

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study.

Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH.

Diabetes. 2009 Jul;58(7):1668-71. doi: 10.2337/db09-0014. Epub 2009 May 1. Erratum in: Diabetes. 2010 Oct;59(10):2695.

13.

Uric acid and long-term outcomes in CKD.

Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V.

Am J Kidney Dis. 2009 May;53(5):796-803. doi: 10.1053/j.ajkd.2008.12.021. Epub 2009 Mar 20.

14.

Risk factors for end-stage renal disease: 25-year follow-up.

Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS.

Arch Intern Med. 2009 Feb 23;169(4):342-50. doi: 10.1001/archinternmed.2008.605.

15.

Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?

Johnson RJ, Perez-Pozo SE, Sautin YY, Manitius J, Sanchez-Lozada LG, Feig DI, Shafiu M, Segal M, Glassock RJ, Shimada M, Roncal C, Nakagawa T.

Endocr Rev. 2009 Feb;30(1):96-116. doi: 10.1210/er.2008-0033. Epub 2009 Jan 16. Review.

16.

Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease.

Navaneethan SD, Beddhu S.

Nephrol Dial Transplant. 2009 Apr;24(4):1260-6. doi: 10.1093/ndt/gfn621. Epub 2008 Nov 25.

17.

The role of hyperuricemia and gout in kidney and cardiovascular disease.

Edwards NL.

Cleve Clin J Med. 2008 Jul;75 Suppl 5:S13-6. Review.

PMID:
18822470
18.

Elevated uric acid increases the risk for kidney disease.

Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R.

J Am Soc Nephrol. 2008 Dec;19(12):2407-13. doi: 10.1681/ASN.2008010080. Epub 2008 Sep 17.

19.

Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells.

Zharikov S, Krotova K, Hu H, Baylis C, Johnson RJ, Block ER, Patel J.

Am J Physiol Cell Physiol. 2008 Nov;295(5):C1183-90. doi: 10.1152/ajpcell.00075.2008. Epub 2008 Sep 10.

20.

Inactivation of nitric oxide by uric acid.

Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson RJ, Henderson GN.

Nucleosides Nucleotides Nucleic Acids. 2008 Aug;27(8):967-78. doi: 10.1080/15257770802257952.

Supplemental Content

Support Center